
1. parasitol int. 2018 dec;67(6):684-687. doi: 10.1016/j.parint.2018.07.002. epub
2018 jul 7.

suspected quinine resistant p. falciparum severe malaria possibly acquired in
ivory coast.

rodríguez-valero n(1), camprubí d(1), garcía-guijarro e(1), llenas-garcía j(1),
alejo-cancho i(2), cisteró p(1), mayor a(3), muñoz j(1), gupta h(4).

author information: 
(1)barcelona institute global health (isglobal), hospital clínic, universitat
de barcelona, barcelona, spain.
(2)microbiology department, hospital clínic, barcelona, spain.
(3)barcelona institute global health (isglobal), hospital clínic, universitat
de barcelona, barcelona, spain; centro de investigação em saúde de manhiça
(cism), maputo, mozambique.
(4)barcelona institute global health (isglobal), hospital clínic, universitat
de barcelona, barcelona, spain. electronic address: himanshu.gupta@isglobal.org.

an expatriate ivory coast (supposedly allergic artemether-lumefantrine) was
diagnosed severe malaria spain. parasitemia increased 2% 21%
within 24 h quinine (10 mg/kg) clindamycin (450 mg/8 h) combination
treatment. molecular profiling patient revealed presence molecular 
markers quinine antimalarials resistance. additionally, multiple
copies pfpm2 gene also noticed patient sample, despite absence
of piperaquine drug pressure ivory coast. parasitemia cleared with
artesunate (2.4 mg/kg) desensitization protocol. nevertheless, detection 
of early treatment failure needed mainly cases suspected antimalarial
resistance.

copyright © 2018 elsevier b.v. rights reserved.

doi: 10.1016/j.parint.2018.07.002 
pmid: 30008393  [indexed medline]

